Challenging the Consensus Statement: Is It Time to Recognise Pharmacological Remission of Type 2 Diabetes?
Study context
- Population
- People with T2D achieving plasma glucose and HbA1c below the diabetes diagnostic threshold
- Outcome
- Proposal: a separate category of T2D remission achieved and maintained mainly with pharmacological treatment
Methodological detailsopinion article
- Opinion article
Main finding
As reported in the abstract
- Current consensus definition of T2D remission excludes absence of diabetes achieved with concomitant glucose- and weight-lowering medications
- Argument 1: similar endocrine mechanisms with bariatric surgery and GLP-1 RA or GIP/GLP-1 dual receptor agonists
- Argument 2: no evidence that effects of near-normoglycaemia from lifestyle, surgery or medications on long-term complications differ
- Argument 3: frequent use of these medications with lifestyle interventions and after bariatric surgery
Original publication
Challenging the Consensus Statement: Is It Time to Recognise Pharmacological Remission of Type 2 Diabetes? Diabetes Obes Metab. Published 19 March 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →